Comment on FR Doc # 2012-30531

Document ID: DEA-2012-0007-0003
Document Type: Public Submission
Agency: Drug Enforcement Administration
Received Date: December 20 2012, at 12:00 AM Eastern Standard Time
Date Posted: December 21 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 19 2012, at 12:00 AM Eastern Standard Time
Comment Due Date: January 18 2013, at 11:59 PM Eastern Standard Time
Tracking Number: 1jw-82ne-3nxe
View Document:  View as format xml

View Comment

Dear DEA: Our country is faced with an obesity epidemic currently in full swing with limited means for physicians to fight this epidemic. Delay is costing lives and billions in costs to address obesity related illnesses. Lorcaserin (Belviq) is the first single agent in history that provides physicians a tool to control this growing danger to our society. Please waive this silly waiting/notice period and make the rule effective immediately! Thank you, in advance, for your attention to this very serious matter.

Related Comments

    View All
Total: 68
Comment on FR Doc # 2012-30531
Public Submission    Posted: 12/21/2012     ID: DEA-2012-0007-0003

Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Public Submission    Posted: 12/21/2012     ID: DEA-2012-0007-0004

Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Public Submission    Posted: 12/21/2012     ID: DEA-2012-0007-0005

Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Public Submission    Posted: 12/21/2012     ID: DEA-2012-0007-0008

Jan 18,2013 11:59 PM ET
Comment on FR Doc # 2012-30531
Public Submission    Posted: 01/04/2013     ID: DEA-2012-0007-0032

Jan 18,2013 11:59 PM ET